Our patents for FOL-005

Follicums’ patent strategy aims to safeguard a patent protection which is as wide as possible. So far we have patents on all important markets for FOL-005 and versions of this peptide; both for stimulation and inhibition of hair growth.

We follow the development of patents in our area and we will pursue a strategy to increase the protection through new patents in the future. The strategy so far is optimising the value of our portfolio with a special focus on the most important markets.

Patent Family

Term

Jurisdiction

Peptides for stimulation of hair growth

2011-2032
Prolongation of the patent term may be possible (for example SPC, PTE) with up to five years in several jurisdictions.

Awaiting approval: BR, CA and IN

Approved: AU, CN, EP, HK, JP, RU, KR and US
Validated in the following countries within EP: AT, BE, CH, DE, DK, ES, FI, FR, GB, IE, IT, LI, NL, NO, PL, SE and TR

Topical formulation

2019-2040
Prolongation of the patent term may be possible (for example SPC, PTE) in several jurisdictions.

PCT application potentially covering 153 jurisdictions